RhoA/Rho-Kinase Suppresses Endothelial Nitric Oxide Synthase in the Penis: A Mechanism for Diabetes-Associated Erectile Dysfunction

Significant impairment in endothelial-derived nitric oxide is present in the diabetic corpus cavernosum. RhoA/Rho-kinase may suppress endothelial nitric oxide synthase (eNOS). Here, we tested the hypothesis that RhoA/Rho-kinase contributes to diabetes-related erectile dysfunction and down-regulation...

Full description

Saved in:
Bibliographic Details
Published inProceedings of the National Academy of Sciences - PNAS Vol. 101; no. 24; pp. 9121 - 9126
Main Authors Bivalacqua, Trinity J., Champion, Hunter C., Usta, Mustafa F., Cellek, Selim, Chitaley, Kanchan, Webb, R. Clinton, Lewis, Ronald L., Mills, Thomas M., Wayne J. G. Hellstrom, Kadowitz, Philip J., Ignarro, Louis J.
Format Journal Article
LanguageEnglish
Published United States National Academy of Sciences 15.06.2004
National Acad Sciences
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Significant impairment in endothelial-derived nitric oxide is present in the diabetic corpus cavernosum. RhoA/Rho-kinase may suppress endothelial nitric oxide synthase (eNOS). Here, we tested the hypothesis that RhoA/Rho-kinase contributes to diabetes-related erectile dysfunction and down-regulation of eNOS in the streptozotocin (STZ-diabetic rat penis. Colocalization of Rho-kinase and eNOS protein was present in the endothelium of the corpus cavernosum. RhoA/Rho-kinase protein abundance and MYPT-1 phosphorylation at Thr-696 were elevated in the STZ-diabetic rat penis. In addition, eNOS protein expression, cavernosal constitutive NOS activity, and cGMP levels were reduced in the STZ-diabetic penis. To assess the functional role of RhoA/Rho-kinase in the penis, we evaluated the effects of an adeno-associated virus encoding the dominant-negative RhoA mutant (AAVTCMV19NRhoA) on RhoA/Rho-kinase and eNOS and erectile function in vivo in the STZ-diabetic rat. STZ-diabetic rats transfected with AAVCMVT19NRhoA had a reduction in RhoA/Rho-kinase and MYPT-1 phosphorylation at a time when cavernosal eNOS protein, constitutive NOS activity, and cGMP levels were restored to levels found in the control rats. There was a significant decrease in erectile response to cavernosal nerve stimulation in the STZ-diabetic rat. AAVT19NRhoA gene transfer improved erectile responses in the STZ-diabetic rat to values similar to control. These data demonstrate a previously undescribed mechanism for the down-regulation of penile eNOS in diabetes mediated by activation of the RhoA/Rho-kinase pathway. Importantly, these data imply that inhibition of RhoA/Rho-kinase improves eNOS protein content and activity thus restoring erectile function in diabetes.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
To whom correspondence should be addressed. E-mail: pkadowi@tulane.edu.
This work was supported by a Young Investigator Award from the International Society for Sexual and Impotence Research (to T.J.B. and H.C.C.), Juvenile Diabetes Research Foundation International (S.C.), and National Institutes of Health Grant HL62000 (to P.J.K.).
This paper was submitted directly (Track II) to the PNAS office.
Abbreviations: MLC, myosin light chain; NOS, NO synthase; eNOS, endothelial NOS; nNOS, neuronal NOS; ED, erectile dysfunction; STZ, streptozotocin; MAP, mean arterial pressure; ICP, intracavernosal pressure; CNS, cavernous nerve stimulation.
Edited by Louis J. Ignarro, University of California School of Medicine, Los Angeles, CA, and approved April 27, 2004
ISSN:0027-8424
1091-6490
DOI:10.1073/pnas.0400520101